Literature DB >> 22135317

Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.

Bob Weijs1, Ron Pisters, Robby Nieuwlaat, Günter Breithardt, Jean-Yves Le Heuzey, Panos E Vardas, Ione Limantoro, Ulrich Schotten, Gregory Y H Lip, Harry J G M Crijns.   

Abstract

AIMS: An age of 60 years is often used as cut-off for the diagnosis of idiopathic atrial fibrillation (AF). We investigated the importance of age and atrial size in patients with idiopathic AF and AF patients with isolated hypertension. METHODS AND
RESULTS: Out of 3978 AF patients in the Euro Heart Survey on AF with known follow-up, 119 (3%) patients had idiopathic AF. We disregarded age and atrial size when selecting idiopathic AF patients since the atria may enlarge by AF itself. For comparison, we selected 152 patients with isolated hypertension from the database. A total of 57 (48%) of the patients were older than 60 years. Persistent or permanent AF was more prevalent in the older idiopathic AF patients (34% in the age <60 vs. 66% in the age >60 years group, P= 0.002) but mean duration of known AF did not differ between these groups [310 days (inter-quartile range, IQR) 60-1827) vs. 430 days (IQR 88-1669), P= 0.824]. Left atrial size did not differ significantly in relation to age (1.50 ± 0.29 mm/kg/m² in the age <60 vs. 1.56 ± 0.31 mm/kg/m² in the age >60 years group, P= 0.742). Only two paroxysmal AF patients progressed to permanent AF. No cardiovascular events occurred during the 1-year follow-up. In contrast, strokes occurred in five patients (6%) with isolated hypertension despite similar clinical profile and comparable atrial size as idiopathic AF patients.
CONCLUSION: Idiopathic AF may present at advanced age and is even then not associated with significant atrial enlargement, AF progression, or an adverse short-term prognosis. In contrast, elevated blood pressure even when found in the absence of significant atrial remodelling, seems of prognostic importance.

Entities:  

Mesh:

Year:  2011        PMID: 22135317     DOI: 10.1093/europace/eur379

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  16 in total

Review 1.  Antiarrhythmic therapy of atrial fibrillation: are we treating too late?

Authors:  Kristina Wasmer; Julia Köbe; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-08-21

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

3.  Myocardial Biopsy In "Idiopathic» Atrial Fibrillation And Other Arrhythmias: Nosological Diagnosis, Clinical And Morphological Parallels, And Treatment.

Authors:  O V Blagova; A V Nedostup; E A Kogan; V A Sulimov; S A Abugov; A G Kupriyanova; V A Zaydenov; A E Donnikov; E V Zaklyazminskaya; E A Okisheva
Journal:  J Atr Fibrillation       Date:  2016-06-30

4.  Lone Atrial Fibrillation: Risk Factors, Triggers And Ablation Techniques.

Authors:  Mindy Vroomen; Laurent Pison
Journal:  J Atr Fibrillation       Date:  2015-06-30

Review 5.  Lone atrial fibrillation: does it exist?

Authors:  D George Wyse; Isabelle C Van Gelder; Patrick T Ellinor; Alan S Go; Jonathan M Kalman; Sanjiv M Narayan; Stanley Nattel; Ulrich Schotten; Michiel Rienstra
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

6.  Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.

Authors:  Mariëlle Kloosterman; Jonas Oldgren; David Conen; Jorge A Wong; Stuart J Connolly; Alvaro Avezum; Salim Yusuf; Michael D Ezekowitz; Lars Wallentin; Marie Ntep-Gweth; Philip Joseph; Tyler W Barrett; Supachai Tanosmsup; William F McIntyre; Shun Fu Lee; Ratika Parkash; Guy Amit; Alex Grinvalds; Isabelle C Van Gelder; Jeff S Healey
Journal:  Europace       Date:  2020-06-01       Impact factor: 5.214

7.  The Convergent Procedure - A Standardised and Anatomic Approach Addresses the Clinical and Economic Unmet Needs of the Persistent Atrial Fibrillation Population.

Authors:  James McKinnie
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11

8.  Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases.

Authors:  Eamp Dudink; B Weijs; Jglm Luermans; Fecm Peeters; S Altintas; K Vernooy; Lafg Pison; R J Haest; J A Kragten; Bljh Kietselaer; J E Wildberger; Hjgm Crijns
Journal:  J Atr Fibrillation       Date:  2020-12-31

9.  Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).

Authors:  Eun-Jeong Kim; Xiaoyan Yin; João D Fontes; Jared W Magnani; Steve A Lubitz; David D McManus; Sudha Seshadri; Ramachandran S Vasan; Patrick T Ellinor; Martin G Larson; Emelia J Benjamin; Michiel Rienstra
Journal:  Am Heart J       Date:  2016-04-30       Impact factor: 4.749

10.  Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review.

Authors:  Rajiv Sankaranarayanan; Graeme Kirkwood; Katharine Dibb; Clifford J Garratt
Journal:  Cardiol Res Pract       Date:  2013-01-22       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.